B S P Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 6.18 M
- Company Age 37 Year, 10 Months
- Open Charges ₹ 2.17 M
About B S P Pharmaceuticals
B S P Pharmaceuticals Limited (BSPPL) is a Public Limited Indian Non-Government Company incorporated in India on 10 April 1987 and has a history of 37 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.18 M.
The company currently has active open charges totaling ₹2.17 M.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1987PLC009556
- Company No.
009556
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Apr 1987
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at B S P Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of B S P Pharmaceuticals.
Enhance accessibility to B S P Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of B S P Pharmaceuticals?
Unlock access to B S P Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.22 Cr
₹0
Charges Breakdown by Lending Institutions
- Gujarat State Financial Corporation : 0.13 Cr
- Central Bank Of India : 0.04 Cr
- Nutan Nagarik Sahakari Bank Limited : 0.03 Cr
- Nutan Nagrik Sahkari Bank Limited : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 1999 | Nutan Nagarik Sahakari Bank Limited | ₹0.26 M | Open |
| 13 Feb 1995 | Nutan Nagrik Sahkari Bank Limited | ₹0.12 M | Open |
| 24 Jan 1994 | Nutan Nagrik Sahkari Bank Limited | ₹0.10 M | Open |
| 02 Jan 1990 | Central Bank Of India | ₹0.30 M | Open |
| 04 Mar 1989 | Gujarat State Financial Corporation | ₹1.27 M | Open |
How Many Employees Work at B S P Pharmaceuticals?
Unlock and access historical data on people associated with B S P Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B S P Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B S P Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.